Trial intelligence / Profile preview

Cardioprotective Effects of Sevoflurane vs Propofol After Cardiac Surgery

ChiCTR-IIR-17010964Phase 4Recruiting

Sponsor
Xinqiao Hospital
Start
Mar 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of sevoflurane and propofol in Cardiac damage (2 arms), sponsored by Xinqiao Hospital. Primary endpoint: Markers of cardiac injury. Started Mar 2017; status: recruiting.

02

Drugs

sevofluranepropofol
03

Conditions

Cardiac damage

Beyond the preview

Go deeper on ChiCTR-IIR-17010964.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IIR-17010964.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call